| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.009 |